Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells - Wikidata - awgldk - TriplyDB

Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells

Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells

http://www.wikidata.org/entity/Q36081961

about

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus Polychromatic flow cytometry in evaluating rheumatic disease patients Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function NKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biology Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.Rationale for B cell targeting in SLE Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells Increased Th2-like Invariant Natural Killer T cells in Peripheral Blood From Patients With Asthma.Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue.Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis.CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors.A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus Germline deletion of β2 microglobulin or CD1d reduces anti-phospholipid antibody, but increases autoantibodies against non-phospholipid antigens in the NZB/W F1 model of lupus B cells interactions in lipid immune responses: implications in atherosclerotic disease.Regulatory B cells in autoimmune diseases.Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?Natural killer T cell based Immunotherapy.B cells participate in tolerance and autoimmunity through cytokine production.Systemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE.Adipose invariant natural killer T cells.B cells in MS and NMO: pathogenesis and therapy.B cells with immune-regulating function in transplantation.The importance of B cell CD1d expression for humoral immunity.Role and regulation of CD1d in normal and pathological B cells.Regulatory B Cells and Mechanisms.The expanding family of regulatory B cells.What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy?Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner.What rheumatologists need to know about innate lymphocytes.Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro Human regulatory B cells in health and disease: therapeutic potential.CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.B cell regulation in cancer and anti-tumor immunity.Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.NKT Cell Responses to B Cell Lymphoma.The quest for personalized B-cell depletion therapy in rheumatic disease.B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.B-1-cell subpopulations contribute differently to gut immunity.

P2860

Q26773074-52E8F240-BD1C-45AA-AD90-57A0C4CF1192 Q26827075-A0C8FC1B-BEA3-46A4-9154-5AE47D41974D Q26830239-9A1913B9-6E48-46A6-9622-BC6D2F7A013D Q27317219-DA38814D-67D9-413E-B103-4E4AC36EA9A8 Q27686770-F04308FE-F221-4D7C-94B2-C2868EE04969 Q33829700-E85D4D89-F28F-4137-8232-ECC64A3F8F27 Q34159795-9C25A3F9-B609-4765-A5AC-D878085751B8 Q34167933-265342FE-0B6E-4C0E-9FC9-BDDAE01C1047 Q34495557-32F57B11-FA14-41B0-8D74-0FC13F51CB67 Q35071875-39A899F7-4D6B-40DC-86AB-E46B24E6B01D Q35129219-FF2F3A3D-2E5B-4327-89A9-A2232F6619F3 Q36351033-C5AEADC4-B205-4A00-BF81-1B0B6181F192 Q36689593-A82847DF-603B-4EF6-A564-5742CB0902B6 Q36718239-AFF0E7E6-EDFA-4BCA-8650-F81231DBD7F9 Q36903316-2C45BBF5-0F89-4248-9DCA-93CF32012AA4 Q37628580-16E184A7-73A0-495F-855C-4BB257FBE063 Q37729359-CFF79E1A-2E6E-4324-A66C-545B87D7B235 Q38063960-287B618C-BC16-4718-AFD6-B0BBA43C5914 Q38148759-EBC6F8E3-725B-4222-B66F-D5048809096F Q38163603-0704253A-7190-4C80-967D-C34BCC3C6E90 Q38171683-E052AA83-46EA-4186-956D-B12BF998C536 Q38199760-323C2DD6-C897-4A81-96EA-B137A500088D Q38212081-ABA2B05A-A2BB-4391-B0EB-E45A953E28D7 Q38213294-83957EBF-3C53-47AD-8984-C123BEB1BF6C Q38221647-70190A65-CA75-48DE-AF49-EB44950FF174 Q38266215-34E0D0AB-9453-4DB9-B4B8-F2EA355851AC Q38385328-01E2290F-51E9-4671-8BFA-3269D446B757 Q38526835-6BD72001-C37A-4FF1-A933-0E800C57371D Q38590248-EF9DC016-5460-4B59-AE6F-54540D24C973 Q38688814-D0C847EF-B56A-4DE3-9B99-CD3BC841F117 Q38809547-9FE94586-3624-4E72-934C-BDC843C66DD3 Q39126180-00F85627-39F0-43C1-B3E2-77A93CB253FD Q39156034-784AE83A-BB26-44F2-9496-B1BE082DF47E Q39230029-F6348922-912E-4BF6-B875-ADA399ACB5FC Q39381508-E7CF29BD-1E10-4018-95DD-419E861D7963 Q39998703-12CFF333-992F-4C0B-90F1-F60143B36EEA Q40894586-CDA81A19-C856-4ABD-9018-1455F7BF1509 Q41482035-FE101ABF-39FA-405A-A887-53EF07C47A0D Q41551818-F591F00D-95EB-41F6-AB11-AFF444194D03 Q44395815-F8B509B3-7B47-422A-8704-0A47A912B15E

P2860

Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells

http://www.wikidata.org/entity/Q36081961

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Lipid-antigen presentation by ...... variant natural killer T cells

@ast

Lipid-antigen presentation by ...... variant natural killer T cells

@en

type

label

Lipid-antigen presentation by ...... variant natural killer T cells

@ast

Lipid-antigen presentation by ...... variant natural killer T cells

@en

prefLabel

Lipid-antigen presentation by ...... variant natural killer T cells

@ast

Lipid-antigen presentation by ...... variant natural killer T cells

@en

P1433

Q36081961-D11C8775-DE5F-4441-97FC-5EEF3EFFD70C

P1476

Q36081961-4E712EDD-8C2A-4341-A727-209EB3DF020C

P2093

Q36081961-5CBC0750-8A0A-4299-8810-F41E5BE6CA18

Q36081961-79B20DA0-AC16-4D04-BC89-3A094F3090D5

Q36081961-ECB3E827-9F7E-49F7-BC00-F40D38A68CDB

P2860

Q36081961-0B722932-DE5A-4F80-AC64-A9851FE0A5EB

Q36081961-0F434AA8-4958-4618-A3F4-1D83BB4EE8B0

Q36081961-25E346E8-8E5F-424A-9C71-3BF51FF0E72D

Q36081961-287BAC17-9AC0-4025-836E-0C6CFE2E2D8B

Q36081961-2D3549E2-396D-485E-BBAF-66EBA120E78E

Q36081961-3ECB5903-406B-400E-9D66-0B8DC4301778

Q36081961-52BB7005-F08F-416C-A389-EA4242A4426E

Q36081961-54AA89CD-AB6E-41F3-922D-3FC99DC2A23C

Q36081961-652B471F-C08B-453F-B0D7-052813FB6DA1

Q36081961-6BA95261-644D-4B34-AD26-873C8D5D8089

P304

Q36081961-E47885C2-4052-4E62-BB67-ADC7C736637D

P31

Q36081961-FE49F0FF-6040-4E7C-B324-A16337D649AD

P356

Q36081961-29F28084-E6B5-483E-A030-35B93403760D

P407

Q36081961-0DD10850-DF4C-4496-8DEE-3270A166E07C

P433

Q36081961-6EAFFBF5-F3DB-411C-B71D-ABEFD802DD56

P478

Q36081961-B7FF6D50-1234-4564-8355-D9A8FF7FDB32

P50

Q36081961-2AC49A9C-4536-47E3-8CD7-B8C6DAD3BBB5

Q36081961-7199E9E7-D453-49AE-B4E0-BF7C44644135

P577

Q36081961-E5882089-C315-4BD6-BE5C-E412ACEC1891

P5875

Q36081961-5CED8460-E012-4C6B-8AF2-5AD719259E29

P698

Q36081961-DA312F0C-5E1F-4A34-A8DE-92C7D4EC454A

P932

Q36081961-BA97AC21-A175-4E55-AE20-E12830F5EC2B

P356

J.IMMUNI.2012.02.008

P1433

P1476

Lipid-antigen presentation by ...... variant natural killer T cells

@en

P2093

Anneleen Bosma

http://www.w3.org/2001/XMLSchema#string

Azza Abdel-Gadir

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Jury

http://www.w3.org/2001/XMLSchema#string

P2860

PD-1 and its ligands in tolerance and immunity

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

Multiple immuno-regulatory defects in type-1 diabetes

CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

Invariant NKT cells sustain specific B cell responses and memory.

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

Glycolipid antigen induces long-term natural killer T cell anergy in mice.

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

P304

477-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2012.02.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

David A. Isenberg

P577

2012-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221692280

http://www.w3.org/2001/XMLSchema#string

P698

22406267

http://www.w3.org/2001/XMLSchema#string

P932

3391684

http://www.w3.org/2001/XMLSchema#string